Advances in the management of disseminated adenovirus disease in stem cell transplant recipients: Impact of adenovirus load (DNAemia) testing

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 11, 2011, Pages 943-945

  Heim, Albert ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

adenovirus; adenovirus load testing; disseminated disease; stem cell transplant recipients

Indexed keywords

CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; RIBAVIRIN; VIRUS DNA;

ANTIVIRAL THERAPY; DISEASE SEVERITY; DISSEMINATED ADENOVIRUS DISEASE; DNA DETERMINATION; DRUG TREATMENT FAILURE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; POLYMERASE CHAIN REACTION; REVIEW; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANTIVIRAL AGENTS; DISEASE MANAGEMENT; DNA, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; VIRAL LOAD; VIRUS REPLICATION;

EID: 80155197746     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.113     Document Type: Review

References (19)

1. Forstmeyer D, Henke-Gendo C, Brocker V, Wildner O, Heim A. Quantitative temporal and spatial distribution of adenovirus type 2 correlates with disease manifestations and organ failure during. disseminated infection. J. Med. Virol. 80(2), 294-297 (2008).
2. Seidemann K, Heim A, Pfister ED et al. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am. J. Transplant. 4(12), 2102-2108 (2004).
3. Kampmann B, Cubitt D, Walls T et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br. J. Haematol. 130(4), 595-603 (2005).
4. La Rosa AM, Champlin Re, Mirza N et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin. Infect. Dis. 32(6), 871-876 (2001).
5. Lion T, Baumgartinger R, Watzinger F et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102(3), 1114-1120 (2003).
6. Cichon G, Boeckh-Herwig S, Schmidt HH et al. Complement activation by recombinant adenoviruses. Gene Ther. 8(23), 1794-1800 (2001).
7. Raper SE, Chirmule N, Lee FS et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80(1-2), 148-158 (2003).
8. Stone D, Liu Y, Shayakhmetov D, Li Zy, Ni S, Lieber A. Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J. Virol. 81(9), 4866-4871 (2007).
9. Claas EC, Schilham MW, De Brouwer CS et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J. Clin. Microbiol. 43(4), 1738-1744 (2005).
10. Gustafson I, Lindblom A, Yun Z et al. Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients. J. Clin. Virol. 43(1), 79-85 (2008).
11. Ganzenmueller T, Buchholz S, Harste G, Dammann E, Trenschel R, Heim A. High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load. J. Clin. Virol. 52(1), 55-59 (2011).
12. Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70(2), 228-239 (2003).
13. Schilham MW, Claas EC, Van Zaane W et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin. Infect. Dis. 35(5), 526-532 (2002).
14. Erard V, Huang MLL, Ferrenberg J et al. Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. Clin. Infect. Dis. 45(8), 958-965 (2007).
15. Morfin F, Dupuis-Girod S, Frobert E et al. Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. Antiviral Ther. 14(1), 55-61 (2009).
16. Lindemans CA, Leen AM, Boelens JJ. How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 116(25), 5476-5485 (2010).
17. Leruez-Ville M, Minard V, Lacaille F et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin. Infect. Dis. 38(1), 45-52 (2004).
18. Toth K, Spencer JF, Dhar D et al. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc. Natl Acad. Sci. USA 105(20), 7293-7297 (2008).
19. Paolino K, Sande J, Perez E et al. Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001. J. Clin. Virol. 50(2), 167-170 (2011).